JP Morgan Chase
SPTX icon

JP Morgan Chase’s Seaport Therapeutics SPTX Stock Holding History

JP Morgan Chase’s Portfolio SPTX Stock Details SPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$29.8M Sell
1,596,602
-219,243
-12% -$4.87M ﹤0.01% 1876
2026
Q2 		$40.9M Buy
+1,815,845
New +$31.9M ﹤0.01% 1621

Other funds holding SPTX

General Atlantic
General Atlantic New York $2.48B AUM 19.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.23B AUM 121.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $126B AUM 27.87% 1-Year Est. Return

JP Morgan Chase's SPTX Position: Q3 2026 in Review

JP Morgan Chase reduced its Seaport Therapeutics (SPTX) stake by 12% in Q3 2026, selling an estimated $4.87M and leaving 1,596,602 shares worth $29.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1876.

JP Morgan Chase first reported a position in SPTX in Q2 2026 and has held it in 2 quarters since. The position peaked at $40.9M in Q2 2026. 40 funds tracked by Wall St. Rank hold SPTX as of Q3 2026.

  • JP Morgan Chase held 1,596,602 shares of Seaport Therapeutics worth $29.8M as of Q3 2026.
  • JP Morgan Chase sold 219,243 Seaport Therapeutics shares in Q3 2026, an estimated $4.87M.
  • Seaport Therapeutics made up ﹤0.01% of JP Morgan Chase's portfolio in Q3 2026, its #1876 holding.
  • JP Morgan Chase first reported a position in Seaport Therapeutics in Q2 2026 and has held it in 2 quarters since.
  • JP Morgan Chase's Seaport Therapeutics position peaked at $40.9M in Q2 2026.
  • 40 funds tracked by Wall St. Rank held Seaport Therapeutics as of Q3 2026.

Based on JP Morgan Chase's 13F filing for Q3 2026, filed 12 Nov 2026.